Nano-X Imaging Ltd.
NASDAQ:NNOXMedical - Devices
Healthcare
$0.73 -1.45%
-$0.03 today
- Market cap
- $50.94M
- Beta
- 1.17
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.12
52W Low $1.59High $5.69
Volume 0.52M
Average 1.46M
Income Statement
Follow revenue through to earnings.
Revenue
$13.02M
FY 2025 · Annual
+15.4% YoYOperating Income
-$60.70M
FY 2025 · Annual
Net Income
-$75.02M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.3M | 8.58M | 9.91M | 11.28M | 13.02M |
| Cost of Revenue | 2.82M | 15.46M | 16.5M | 21.89M | 25.81M |
| Gross Profit | (1.51M) | (6.88M) | (6.59M) | (10.61M) | (12.79M) |
| Gross Margin | -116.0% | -80.2% | -66.6% | -94.0% | -98.2% |
| Research & Development | 17.12M | 26.51M | 26.05M | 20.18M | 19.24M |
| Selling, General & Admin | 41.74M | 45.63M | 28.39M | 25.75M | 27.1M |
| Operating Expenses | 60.05M | 72.33M | 56M | 46.14M | 47.91M |
| Depreciation & Amortization | 2.29M | 11.51M | 11.81M | 11.73M | 11.7M |
| EBITDA | (59.27M) | (75.7M) | (47.69M) | (45.01M) | (49M) |
| EBITDA Margin | -4544.9% | -882.4% | -481.5% | -398.9% | -376.3% |
| Operating Income | (61.56M) | (109.71M) | (62.59M) | (56.75M) | (60.7M) |
| Operating Margin | -4720.7% | -1279.0% | -631.9% | -502.9% | -466.2% |
| Interest Income | 0 | 789K | 1.65M | 2.87M | 1.42M |
| Interest Expense | 288K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (288K) | (14.67M) | 1.47M | 2.87M | (16.11M) |
| Income Before Tax | (61.85M) | (108.92M) | (61.12M) | (53.87M) | (76.81M) |
| Pre-Tax Margin | -4742.8% | -1269.8% | -617.0% | -477.5% | -589.9% |
| Income Tax Expense | (48K) | (3.68M) | (339K) | (358K) | (1.79M) |
| Net Income | (61.8M) | (105.24M) | (60.78M) | (53.52M) | (75.02M) |
| Net Margin | -4739.1% | -1226.9% | -613.6% | -474.3% | -576.1% |
| EPS (Basic) | (1.28) | (2.01) | (1.08) | (0.91) | (1.16) |
| EPS (Diluted) | (1.28) | (2.01) | (1.08) | (0.91) | (1.16) |
| 48.22M | 52.24M | 56.37M | 58.62M | 64.79M | |
| 48.22M | 52.24M | 56.37M | 58.62M | 64.79M |
NNOX Earnings Waterfall · TTM
NASDAQ:NNOX · Revenue to Net Income
Key Ratios
EPS$-1.15
Gross Margin-98.9%
Net Margin-562.2%
P/E Ratio-4.4
P/S Ratio85.5
Analysis
$13.0M of revenue converted into -$75.0M of net income for the selected period. Gross margin is -98.9% and net margin is -562.2%, showing how much revenue survives after costs and taxes. EPS is $-1.15, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Sep 9, 2026 | |
| 6-K | 6-K filing | Aug 18, 2026 | |
| 6-K | 6-K filing | Aug 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 11, 2026 | |
| 424B5 | 424B5 filing | Aug 7, 2026 |
How much revenue does NNOX generate?
Nano-X Imaging Ltd. (NNOX) reported $13.02M of revenue in fiscal 2025.
Is NNOX profitable?
Nano-X Imaging Ltd. (NNOX) reported -$75.02M of net income, with a net margin of -576.1%.
Continue the stock analysis
Jump to another research area for this company.